SCHEMBL16974835

SCHEMBL16974835

Clc1cc2c(cc1Cl)SN=C(NCCc1ccccn1)N2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
LMNA P02545 3/20 0.41
MAPT P10636 3/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HTT P42858 3/20 0.40
PKM P14618 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HRH3 Q9Y5N1 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
ALOX15 P16050 1/20 0.39
KDM4E B2RXH2 2/20 0.38
CNR1 P21554 1/20 0.38
NPC1 O15118 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
GLA P06280 1/20 0.37
APP P05067 2/20 0.37
PIM1 P11309 1/20 0.37
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16974865 0.87 PKM (0.47) CYP1A2LMNAMAPTKMT2AALDH1A1
SCHEMBL16974849 0.86 CYP1A2 (0.44) CYP1A2LMNAKMT2AALDH1A1HTT
SCHEMBL8664923 0.83 CYP1A2 (0.43) CYP1A2LMNAKMT2AALDH1A1HTT
SCHEMBL16974908 0.82 CYP1A2 (0.42) CYP1A2LMNAMAPTKMT2AALDH1A1
SCHEMBL16974887 0.80 GSK3B (0.36) CYP1A2HTTSMN1; SMN2TAAR1KDM4E
SCHEMBL16974905 0.75 ALDH1A1 (0.46) CYP1A2KMT2AALDH1A1HTTRAB9A
SCHEMBL16974823 0.75 ALDH1A1 (0.46) CYP1A2KMT2AALDH1A1HTTPKM
SCHEMBL16974923 0.75 CYP1A2 (0.42) CYP1A2LMNAKMT2AALDH1A1HTT
SCHEMBL7957415 0.75 PKM (0.43) CYP1A2LMNAMAPTKMT2AALDH1A1
SCHEMBL16974827 0.74 MAOA (0.41) CYP1A2MAPTKMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099304-A1 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA Mayo Foundation for Medical Education and Research (US) 2016-12-07 EP disclosed
WO-2015117024-A1 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2015-08-06 WO disclosed